Abstract:
There are provided a compound of Formula (1) and a labeled biological substance having the compound.
Z1 and Z2 represent a specific 6-membered ring. However, at least one of Z1 or Z2 is a benzene ring having a specific substituent at an ortho position with respect to a nitrogen atom to which L1 or L2 is bonded, or a specific nitrogen-containing 6-membered ring in which a ring-constituting atom located at the ortho position is a nitrogen atom. R1 to R4, R11 to R13, L1, L2, and R21 represents specific groups, and n, α1, α2, and m represent specific numbers. The compound has at least one structure represented by —(CH2—CH2—O)m-R21 on a heterocyclic ring and has at least one substituent capable of being bonded to a carboxy group or a biological substance at a specific position, and in a case where at least one of Z1 or Z2 is the specific nitrogen-containing 6-membered ring, the specific substituents may be bonded to each other to form a ring.
Abstract:
Provided are any one of the following compounds and a fluorescently labeled biological substance having this compound. R1 to R27, L11, L12, and X+ represent a specific group, and at least one of R1 to R4 represents a substituted alkyl group. In a case where at least one of R1 to R4 is an alkyl group having a carboxy group or a substituent capable of being bonded to a biological substance, at least one of R11 to R27 is an alkyl group or an aryl group, or at least one of R1 to R4, which does not correspond to the alkyl group having a carboxy group or an alkyl group having a substituent capable of being bonded to a biological substance, is an alkyl group having a sulfoalkyl group through a single bond or a linking group. The total of n1 to n4 is an integer of 3 or more, and m=n1+n2+n3+n4−1 is satisfied. At least one of R1 to R4, R13, L11 or L12 in Formula (1) and at least one of R1 to R4, R24, L11, or L12 in Formula (2) have a specific substituent.
Abstract:
Provided are a particle including a polymer P including a bond U that is at least one selected from the group consisting of a urethane bond and a urea bond, and a hydrophilic group, a polymerizable monomer, and a moiety A that is at least one selected from the group consisting of a polysiloxane bond and a fluorinated hydrocarbon group; an aqueous dispersion; an ink jet ink; a film-forming method; and an image-forming method.
Abstract:
The present invention is to provide a photoelectric conversion element with an excellent photoelectric conversion efficiency, an imaging element, an optical sensor, and a compound. The photoelectric conversion element of the present invention includes, in the following order, a conductive film, a photoelectric conversion film, and a transparent conductive film, in which the photoelectric conversion film contains a compound represented by Formula (1).
Abstract:
A producing method of a plasma polymerized film includes irradiating a composition containing at least one kind of radically polymerizable compound, and at least one of a polymerization initiator and a chain transfer agent with plasma.The plasma polymerized film is formed by polymerizing a composition containing at least one of a polymerization initiator and a chain transfer agent, and at least one kind of radically polymerizable compound by irradiation of plasma.
Abstract:
An object of the present invention is to provide a photoelectric conversion element which has excellent manufacturing suitability and also has excellent photoelectric conversion efficiency, an imaging element, an optical sensor, and a compound. A photoelectric conversion element according to the present invention including in the following order, a conductive film, a photoelectric conversion film, and a transparent conductive film, in which the photoelectric conversion film contains a compound represented by Formula (1).
Abstract:
The present invention is to provide a photoelectric conversion element with the electric field strength dependence of a photoelectric conversion efficiency suppressed. In addition, an imaging element, an optical sensor, and a compound are provided. The photoelectric conversion element includes a conductive film, a photoelectric conversion film, and a transparent conductive film in this order, in which the photoelectric conversion film contains a compound represented by Formula (1).
Abstract:
There are provided a compound of Formula (1) and a labeled biological substance having the compound.
R1 to R6, R11 to R13, and R22 to R29 represent specific groups, and n is an integer of 1 to 3. One selected from R1, R2, R5, R22 to R25 and one selected from R3, R4, R6, and R26 to R29 are bonded through a linking group LL. The linking group LL represents a linking group having 1 to 100 atoms, which does not have any one of an aromatic hydrocarbon ring, a sulfo group, or a phosphono group. R1, . . . , R6, R22, . . . , or R29 includes a structure represented by —(CH2—CH2—O)m—, where m is 1 to 50. The above-described compound is a neutral compound and contains at least one substituent capable of being bonded to a carboxy group or a biological substance.
Abstract:
A photoelectric conversion element has a conductive support, a photoreceptor layer containing an electrolyte, a charge carrier layer containing an electrolyte and a counter electrode, and the photoreceptor layer has semiconductor particles on which a metal complex dye represented by Formula (I) is carried. M1(LA)(LD)(Z1).CI Formula (I) M1 represents a metal atom; Z1 represents a monodentate ligand; LA represents a tridentate ligand represented by Formula (AL-1); LD represents a bidentate ligand represented by Formula (DL-1); and CI represents a counterion necessary for neutralizing the charge.